Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Annals of Hematology|June 28, 2018
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group databaseIsao Fujioka, Tomoiku Takaku, Noriyoshi Iriyama, et al.Journal of Clinical and Experimental Hematopathology : JCEH|May 15, 2020
The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disordersMichihide Tokuhira, Yuka Tanaka, Yasuyuki Takahashi, et al.International Journal of Hematology|April 23, 2008
Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansionMichihide Tokuhira, Atsushi Iizuka, Reiko Watanabe, et al.International Journal of Hematology|April 8, 2024
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study GroupNoriyoshi Iriyama, Eisaku Iwanaga, Yuta Kimura, et al.Cardio-Oncology (London, England)|July 19, 2025
The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsNaoki Watanabe, Tomoiku Takaku, Noriyoshi Iriyama, et al.International Journal of Hematology|May 2, 2023
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effectsMichihide Tokuhira, Yuta Kimura, Takayuki Tabayashi, et al.International Journal of Hematology|December 13, 2025
Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemiaKohjin Suzuki, Tomoiku Takaku, Naoki Watanabe, et al.The American Journal of Surgical Pathology|May 23, 2019
Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic FactorsDaisuke Kurita, Hiroaki Miyoshi, Ayako Ichikawa, et al.Medical Oncology (Northwood, London, England)|May 31, 2018
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitorsTomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, et al.Annals of Medicine|April 29, 2022
Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitorsYuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, et al.Pageof 6